What's new

EMEA-002559-PIP09-23

EMEA-002559-PIP09-23

Mar 14, 2025 - 13:55
 0
EMEA-002559-PIP09-23
EMEA-002559-PIP09-23
Read More

Tags:

Previous Article

Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis anti...

Next Article

Sibanye-Stillwater confirms loss of life at Driefontein

Related Posts

Orphan designation: Adeno-associated viral vector serotype rh10 containing the human cholesterol 24-hydroxylase gene Treatment of Huntington’s disease, 01/04/2019 Withdrawn

Orphan designation: Adeno-associated viral vector serot...

Mar 12, 2025  0

EMEA-003500-PIP01-23

EMEA-003500-PIP01-23

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0